ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36902
-0.01%
Bitcoin
64,234.42
0.37%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Alligator Bioscience Ab (0RK9)

  7. Alligator Bioscience Ab (0RK9) News

0RK9

Alligator Bioscience Ab (0RK9)

Alligator Bioscience Ab
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0RK9
DateTimeSourceHeadlineSymbolCompany
04/01/20221:20AMPR Newswire (US)Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort CommencesLSE:0RK9Alligator Bioscience Ab
04/01/20221:19AMPR Newswire (US)Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort CommencesLSE:0RK9Alligator Bioscience Ab
03/23/20223:07AMPR Newswire (US)Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kgLSE:0RK9Alligator Bioscience Ab
03/23/20223:06AMPR Newswire (US)Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kgLSE:0RK9Alligator Bioscience Ab
02/11/20221:23AMPR Newswire (US)Alligator Bioscience AB: Year End report January-December 2021LSE:0RK9Alligator Bioscience Ab
02/11/20221:22AMPR Newswire (US)Alligator Bioscience AB: Year End report January-December 2021LSE:0RK9Alligator Bioscience Ab
02/01/20222:16AMPR Newswire (US)Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical OfficerLSE:0RK9Alligator Bioscience Ab
02/01/20221:20AMPR Newswire (US)Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical OfficerLSE:0RK9Alligator Bioscience Ab
01/19/20221:42AMPR Newswire (US)Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory BeattyLSE:0RK9Alligator Bioscience Ab
01/19/20221:41AMPR Newswire (US)Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory BeattyLSE:0RK9Alligator Bioscience Ab
01/18/20221:19AMPR Newswire (US)Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects ReportedLSE:0RK9Alligator Bioscience Ab
01/18/20221:16AMPR Newswire (US)Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects ReportedLSE:0RK9Alligator Bioscience Ab
12/16/20211:41AMPR Newswire (US)Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability DataLSE:0RK9Alligator Bioscience Ab
12/16/20211:39AMPR Newswire (US)Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability DataLSE:0RK9Alligator Bioscience Ab
12/15/20217:37AMPR Newswire (US)Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal Nature CommunicationLSE:0RK9Alligator Bioscience Ab
12/15/20217:36AMPR Newswire (US)Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal Nature CommunicationLSE:0RK9Alligator Bioscience Ab
11/08/202110:54AMPR Newswire (US)Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University RotterdamLSE:0RK9Alligator Bioscience Ab
11/08/202110:53AMPR Newswire (US)Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University RotterdamLSE:0RK9Alligator Bioscience Ab
11/08/20219:59AMPR Newswire (US)Bulletin from the extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
11/08/20219:57AMPR Newswire (US)Bulletin from the extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
10/21/20211:45AMPR Newswire (US)Alligator Bioscience AB: Interim report January-September 2021LSE:0RK9Alligator Bioscience Ab
10/21/20211:41AMPR Newswire (US)Alligator Bioscience AB: Interim report January-September 2021LSE:0RK9Alligator Bioscience Ab
10/07/20211:25AMPR Newswire (US)Notice of extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
10/07/20211:23AMPR Newswire (US)Notice of extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
09/02/20215:17AMPR Newswire (US)Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipelineLSE:0RK9Alligator Bioscience Ab
09/02/20215:14AMPR Newswire (US)Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipelineLSE:0RK9Alligator Bioscience Ab
09/02/20213:33AMPR Newswire (US)Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination TherapyLSE:0RK9Alligator Bioscience Ab
08/18/20211:50AMPR Newswire (US)Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion CorporationLSE:0RK9Alligator Bioscience Ab
08/18/20211:49AMPR Newswire (US)Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion CorporationLSE:0RK9Alligator Bioscience Ab
08/16/20218:16AMPR Newswire (US)Alligator Bioscience Announces New Senior Director of Communications & Investor RelationsLSE:0RK9Alligator Bioscience Ab
 Showing the most relevant articles for your search:LSE:0RK9

Your Recent History

USOTC
CYDY
CytoDyn (QB)
USOTC
VPLM
Voip Pal Com (QB)
COIN
SHIBUSD
SHIBA INU
NASDAQ
COOP
Mr Cooper
USOTC
SPZI
Spooz (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
TGLO
TheGlobe com (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
AMRN
Amarin
NASDAQ
LWLG
Lightwave Logic
NASDAQ
DJT
Trump Media and Technology
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
AGBA
AGBA
NASDAQ
AVXL
Anavex Life Sciences
USOTC
TPTW
TPT Global Tech (CE)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved